These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22530579)

  • 1. Metabotropic glutamate receptors: a review on prospectives and therapeutic aspects.
    Vaidya A; Jain S; Jain AK; Agrawal A; Kashaw SK; Jain SK; Agrawal RK
    Mini Rev Med Chem; 2013 Nov; 13(13):1967-81. PubMed ID: 22530579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
    Ritzén A; Mathiesen JM; Thomsen C
    Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):202-13. PubMed ID: 16176554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and modulation of metabotropic glutamate receptors.
    Rondard P; Pin JP
    Curr Opin Pharmacol; 2015 Feb; 20():95-101. PubMed ID: 25529199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.
    Gasparini F; Kuhn R; Pin JP
    Curr Opin Pharmacol; 2002 Feb; 2(1):43-9. PubMed ID: 11786307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor orthosteric ligands and their binding sites.
    Acher FC; Cabayé A; Eshak F; Goupil-Lamy A; Pin JP
    Neuropharmacology; 2022 Feb; 204():108886. PubMed ID: 34813860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
    Kew JN
    Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptors and neurodegenerative diseases.
    Ribeiro FM; Vieira LB; Pires RG; Olmo RP; Ferguson SS
    Pharmacol Res; 2017 Jan; 115():179-191. PubMed ID: 27872019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
    Litim N; Morissette M; Di Paolo T
    Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group I metabotropic glutamate receptor signalling and its implication in neurological disease.
    Ribeiro FM; Paquet M; Cregan SP; Ferguson SS
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):574-95. PubMed ID: 20632969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.
    Pin JP; Acher F
    Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):297-317. PubMed ID: 12769621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders.
    Bruno V; Caraci F; Copani A; Matrisciano F; Nicoletti F; Battaglia G
    Neuropharmacology; 2017 Mar; 115():180-192. PubMed ID: 27140693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group I metabotropic glutamate receptors: implications for brain diseases.
    Bordi F; Ugolini A
    Prog Neurobiol; 1999 Sep; 59(1):55-79. PubMed ID: 10416961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
    Chiechio S
    Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
    Luján-Miras R
    Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists and antagonists for group III metabotropic glutamate receptors 6, 7 and 8.
    Yang ZQ
    Curr Top Med Chem; 2005; 5(9):913-8. PubMed ID: 16178735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutamate Metabotropic Receptors: Structure, Localisation, Functions].
    Perfilova VN; Tyurenkov IN
    Usp Fiziol Nauk; 2016; 47(2):98-112. PubMed ID: 27530046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
    Gregory KJ; Noetzel MJ; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors: physiology, pharmacology, and disease.
    Niswender CM; Conn PJ
    Annu Rev Pharmacol Toxicol; 2010; 50():295-322. PubMed ID: 20055706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate 1 receptor: current concepts and perspectives.
    Ferraguti F; Crepaldi L; Nicoletti F
    Pharmacol Rev; 2008 Dec; 60(4):536-81. PubMed ID: 19112153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.